Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Expert Opinion on Drug Discovery Année : 2016

Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery

Résumé

Peptides have gained renewed interest as candidate therapeutics. However, to bring them to a broader clinical use, challenges such as the rational optimization of their pharmacological properties remain. Peptide scanning techniques offer a systematic framework to gain information on the functional role of individual amino acids of a peptide. Due to progress in mastering new chemical synthesis routes targeting amino acid backbone, they are currently diversified. Structure-activity relationship (SAR) analyses such as alanine- or enantioneric- scanning can now be supplemented by N-substitution, lactam cyclisation- or aza-amino scanning procedures addressing not only SAR considerations but also the peptide pharmacological properties.
Fichier non déposé

Dates et versions

hal-01962730 , version 1 (20-12-2018)

Identifiants

Citer

Stéphanie Eustache, Jérôme Leprince, Pierre Tufféry. Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery. Expert Opinion on Drug Discovery, 2016, 11 (8), pp.771-784. ⟨10.1080/17460441.2016.1201058⟩. ⟨hal-01962730⟩
61 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More